AC3 Trademark
AC3 is a USPTO trademark filed by SABINSA CORPORATION. Status: Registered.
Prosecution Summary
Trademark Summary
The mark AC3 consists of stylized letters "A", "C", and a superscript "3" over the "C", covering plant extracts such as standardized curcuma longa extract and curcuminoids for use as ingredients in the manufacture of dietary and nutritional supplements in Class 001 (with additional classes 005, 006, 010, 026, and 046 listed). It is owned by Sabinsa Corporation of East Windsor, New Jersey. The mark is registered on the Principal Register since August 15, 2023 (Reg. No. 7141084). A security interest assignment to Citizens Bank, N.A. was recorded on October 7, 2025.
Recent Activity
Filed September 8, 2022, under intent-to-use basis (later converted via statement of use), the mark was published for opposition on November 22, 2022, and issued a not
Trademark Facts
| Mark | AC3 |
|---|---|
| Serial Number | 97583485 |
| Registration Number | 7141084 |
| Status | Registered |
| Filing Date | 2022-09-08 |
| Registration Date | 2023-08-15 |
| Mark Type | Stylized |
| Nice Classes | 001 (Chemicals) |
| Owner | SABINSA CORPORATION |
| Prosecution Events | 20 |
| Latest Event | NRCC on 2023-08-15 |
Goods & Services
Plant extracts, namely, standardised curcuma longa extract containing curcumin, bisdemethoxycurcumin, and demethoxycurcumin, for use as an ingredient in the manufacture of dietary and nutritional supplements; Plant extracts, namely, curcuminoids comprised of curcumin, bisdemethoxycurcumin, and demethoxycurcumin for use as ingredients in the manufacture of dietary and nutritional supplements; Plant extracts, namely, active curcuminoids, for use in the manufacture of dietary and nutritional supplements; Plant extracts, namely, curcuma longa extract standardized to contain curcumin, bisdemethoxycurcumin, and demethoxycurcumin, for use in the manufacture of dietary and nutritional supplements